The arylhydrocarbon receptor is only marginally involved in the antileukemic effects of its ligand curcumin

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4657-4664

  Goergens, Andreas ^a   Frericks, Markus ^a   Esser, Charlotte ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

AhR; AML; Apoptosis; Cell cycle; Curcumin; HL 60

Indexed keywords

ARYLHYDROCARBON RECEPTOR; CALCITRIOL; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CELL DNA; CURCUMIN; FLAVONE DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CELL CYCLE ARREST; CELL LEVEL; CELL STRAIN HL 60; CELL VIABILITY; DNA CONTENT; DNA DETERMINATION; DRUG RECEPTOR BINDING; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ACUTE DISEASE; APOPTOSIS; BENZOFLAVONES; CASPASES; CELL CYCLE; CURCUMIN; ENZYME ACTIVATION; FLAVONOIDS; HL-60 CELLS; HUMANS; ISOENZYMES; LEUKEMIA, MYELOID; LIGANDS; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 75149161601     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Smith M, Barnett M, Bassan R, Gatta G, Tondini C and Kern W: Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 50: 197-222, 2004.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
3. Steriti R: Nutritional support for chronic myelogenous and other leukemias: a review of the scientific literature. Altern Med Rev 7: 404-409, 2002.
4. Formica JV and Regelson W: Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33: 1061-1080, 1995.
5. Anto RJ, George J, Babu KV, Rajasekharan KN and Kuttan R: Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res 370: 127-131, 1996.
6. 2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280: 20059-20068, 2005.
7. Hsu CH and Cheng AL: Clinical studies with curcumin. Adv Exp Med Biol 595: 471-480, 2007.
8. 1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2). Methods Find Exp Clin Pharmacol 29: 179-183, 2007.
9. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S and Sethi G: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol 73: 1024-1032, 2007.
10. Yang CS, Landau JM, Huang MT and Newmark HL: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21: 381-406, 2001.
11. Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, Ryan XP, Magiatis P, Polychronopoulos P, Greengard P, Skaltsounis L and Meijer L: Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 23: 4400-4412, 2004.
12. Ciolino HP, Daschner PJ and Yeh GC: Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 340(Pt 5): 715-722, 1999.
13. Schmidt JV and Bradfield CA: Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55-89, 1996.
14. Denison MS and Nagy SR: Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-334, 2003.
15. Elferink CJ: Aryl hydrocarbon receptor-mediated cell cycle control. Prog Cell Cycle Res 5: 261-267, 2003.
16. Birnie GD: The HL60 cell line: a model system for studying human myeloid cell differentiation. Br J Cancer Suppl 9: 41-45, 1988.
17. Martin D, Bran C, Remy E, Mouren P, Thieffry D and Jacq B: GOToolBox: functional analysis of gene datasets based on Gene Ontology. Genome Biol 5: R101, 2004.
18. Danial NN: BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13: 7254-7263, 2007.
19. Inoue S: Analyses of cell cycle and DNA. Rinsho Byori 49: 835-841, 2001.
20. Fritsche E, Schafer C, Calles C, Bernsmann T, Bernshausen T, Wurm M, Hubenthai U, Cline JE, Hajimiragha H, Schroeder P, Klotz LO, Rannug A, Furst P, Hanenberg H, Abel J and Kratmann J: Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 104: 8851-8856, 2007.
21. Frericks M, Burgoon LD, Zacharewski TR and Esser C: Promoter analysis of TCDD-inducible genes in a thymic epithelial cell line indicates the potential for cell-specific transcription factor crosstalk in the AhR response. Toxicol Appl Pharmacol 232: 268-279, 2008.
22. Kanli A and Savli H: Differential expression of 16 genes coding for cell cycle- and apoptosis-related proteins in vitamin D-induced differentiation of HL-60 cells. Exp Oncol 29: 314-316, 2007.
23. Efferth T, Fu YJ, Zu YG, Schwarz G, Konkimalla VS and Wink M: Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Curr Med Chem 14: 2024-2032, 2007.
24. Syng-Ai C, Kumari AL and Khar A: Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3: 1101-1108, 2004.
25. Gasiewicz TA, Henry EC and Collins LL: Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit Rev Eukaryot Gene Expr 18: 279-321, 2008.
26. Aggarwal BB and Shishodia S: Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann NY Acad Sci 1030: 434-441, 2004.
27. Pang PH, Lin YH, Lee YH, Hou HH, Hsu SP, and Juan SH: Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells. J Cell Physiol 215: 161-171, 2008.
28. Matikainen T, Perez GI, Jurisicova A, Pra JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH, and Tilly JL: Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 28: 355-360, 2001.
29. 1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70: 700-713, 2005.
30. Frericks M, Meissner M, and Esser C: Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol Appl Pharmacol 220: 320-332, 2007.
31. Suzuki T and Nohara K: Regulatory factors involved in species-specific modulation of arylhydrocarbon receptor (AhR)-dependent gene expression in humans and mice. J Biochem 142: 443-452, 2007.
32. Nagy SR, Liu G, Lam KS and Denison MS: Identification of novel Ah receptor agonists using a high-throughput green fluorescent protein-based recombinant cell bioassay. Biochemistry 41: 861-868, 2002.
33. Adachi J, Mori Y, Matsui S and Matsuda T: Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-ρ-dioxin and a natural arylhydrocarbon receptor ligand, indirabin. Toxicol Sei 80: 161-169, 2004.
34. Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA, III, Kato T, Saeki K and Matsuda T: Indirabin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 276: 31475-31478, 2001.
35. Sinai CJ, Webb CD and Bend JR: Differential in vivo effects of alpha-naphthoflavone and beta-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney. J Biochem Mol Toxicol 13: 29-40, 1999.
36. Lee JC, Kim J, Park JK, Chung GH and Jang YS: The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Exp Cell Res 291: 386-397, 2003.
37. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
38. Safe S, Qin C, and McDougal A: Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer. Expert Opin Investig Drags 8: 1385-1396, 1999.